Mahnaz Shekari

2.8k total citations
38 papers, 417 citations indexed

About

Mahnaz Shekari is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mahnaz Shekari has authored 38 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 18 papers in Physiology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mahnaz Shekari's work include Dementia and Cognitive Impairment Research (25 papers), Alzheimer's disease research and treatments (17 papers) and Medical Imaging Techniques and Applications (9 papers). Mahnaz Shekari is often cited by papers focused on Dementia and Cognitive Impairment Research (25 papers), Alzheimer's disease research and treatments (17 papers) and Medical Imaging Techniques and Applications (9 papers). Mahnaz Shekari collaborates with scholars based in Spain, United Kingdom and Sweden. Mahnaz Shekari's co-authors include Juan Domingo Gispert, Gemma Salvadó, Gill Farrar, Christopher Buckley, Lyduine E. Collij, Frederik Barkhof, Andrew Stephens, Santiago Bullich, Kaj Blennow and José Luís Molinuevo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Mahnaz Shekari

34 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahnaz Shekari Spain 12 217 196 118 74 74 38 417
Ping Chiao United States 8 266 1.2× 242 1.2× 101 0.9× 84 1.1× 60 0.8× 19 436
Anna Dewenter Germany 11 192 0.9× 131 0.7× 96 0.8× 140 1.9× 68 0.9× 24 368
Elles Konijnenberg Netherlands 13 170 0.8× 211 1.1× 275 2.3× 106 1.4× 47 0.6× 22 526
Michelle Zanette Sweden 7 224 1.0× 229 1.2× 86 0.7× 82 1.1× 35 0.5× 9 315
David N. Soleimani‐Meigooni United States 13 292 1.3× 253 1.3× 112 0.9× 109 1.5× 81 1.1× 29 548
Jenna Stevenson Canada 8 307 1.4× 251 1.3× 60 0.5× 92 1.2× 61 0.8× 36 440
Emma M. Coomans Netherlands 12 264 1.2× 208 1.1× 110 0.9× 137 1.9× 76 1.0× 25 461
Daisuke Yanase Japan 12 226 1.0× 211 1.1× 147 1.2× 111 1.5× 78 1.1× 21 516
Dawn Cutler United Kingdom 5 331 1.5× 280 1.4× 117 1.0× 128 1.7× 85 1.1× 8 508
Beth Kuczynski United States 7 173 0.8× 155 0.8× 92 0.8× 100 1.4× 74 1.0× 8 410

Countries citing papers authored by Mahnaz Shekari

Since Specialization
Citations

This map shows the geographic impact of Mahnaz Shekari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahnaz Shekari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahnaz Shekari more than expected).

Fields of papers citing papers by Mahnaz Shekari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahnaz Shekari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahnaz Shekari. The network helps show where Mahnaz Shekari may publish in the future.

Co-authorship network of co-authors of Mahnaz Shekari

This figure shows the co-authorship network connecting the top 25 collaborators of Mahnaz Shekari. A scholar is included among the top collaborators of Mahnaz Shekari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahnaz Shekari. Mahnaz Shekari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Escalante, Armand, Marta Milà‐Alomà, Wagner S. Brum, et al.. (2025). A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer’s disease. EBioMedicine. 116. 105741–105741. 3 indexed citations
2.
Suárez‐Calvet, Marc, Marta Milà‐Alomà, Juan Domingo Gispert, et al.. (2025). Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease. Neurology. 105(9). e214308–e214308. 1 indexed citations
3.
Sánchez‐Benavides, Gonzalo, Maríateresa Buongiorno, Alejandro de la Sierra, et al.. (2025). Blood pressure and Alzheimer’s disease biomarkers in cognitively unimpaired adults: a multicenter study. The Journal of Prevention of Alzheimer s Disease. 12(10). 100304–100304.
4.
Bollack, Ariane, Lyduine E. Collij, Mahnaz Shekari, et al.. (2024). The Centiloid scale: guidance on clinical context of use from the AMYPAD Consortium. Alzheimer s & Dementia. 20(S2). 1 indexed citations
5.
Collij, Lyduine E., Ariane Bollack, Renaud La Joie, et al.. (2024). Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium. Alzheimer s & Dementia. 20(12). 9037–9048. 22 indexed citations
6.
Shekari, Mahnaz, David Vállez García, Lyduine E. Collij, et al.. (2024). Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology. Alzheimer s & Dementia. 20(8). 5102–5113. 14 indexed citations
7.
Peña-Gómez, Cleofé, Marina García-Prat, Mahnaz Shekari, et al.. (2024). Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer’s disease. Alzheimer s Research & Therapy. 16(1). 274–274. 5 indexed citations
8.
Sánchez‐Benavides, Gonzalo, Marta Milà‐Alomà, Mahnaz Shekari, et al.. (2023). The associations between glial biomarkers and cognitive changes in individuals at risk of Alzheimer’s disease. Alzheimer s & Dementia. 19(S24). 1 indexed citations
9.
Pelkmans, Wiesje, Mahnaz Shekari, Anna Brugulat‐Serrat, et al.. (2023). Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression. Alzheimer s & Dementia. 20(1). 483–493. 47 indexed citations
10.
Milà‐Alomà, Marta, Anna Brugulat‐Serrat, Gonzalo Sánchez‐Benavides, et al.. (2023). Reproductive span as a modifier of the association between AD biomarkers and cognitive decline in cognitively unimpaired women. Alzheimer s & Dementia. 19(S22). 1 indexed citations
11.
Falcón, Carles, Grégory Operto, Mahnaz Shekari, et al.. (2023). Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD. Alzheimer s & Dementia. 19(12). 5371–5386. 9 indexed citations
12.
Shekari, Mahnaz, Eline E. Verwer, Maqsood Yaqub, et al.. (2023). Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan. EJNMMI Physics. 10(1). 68–68. 15 indexed citations
13.
Pemberton, Hugh, Lyduine E. Collij, Fiona Heeman, et al.. (2022). Quantification of amyloid PET for future clinical use: a state-of-the-art review. European Journal of Nuclear Medicine and Molecular Imaging. 49(10). 3508–3528. 104 indexed citations
14.
Shekari, Mahnaz, David Vállez García, Lyduine E. Collij, et al.. (2022). Evaluating the sensitivity of Centiloid quantification to pipeline design and image resolution. Alzheimer s & Dementia. 18(S6). 1 indexed citations
15.
Shekari, Mahnaz, David Vállez García, Lyduine E. Collij, et al.. (2022). Evaluating the sensitivity of Centiloid quantification to pipeline design and image resoloution. Alzheimer s & Dementia. 18(S6). 1 indexed citations
16.
Lantero‐Rodriguez, Juan, Anniina Snellman, Andréa L. Benedet, et al.. (2021). P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease. EMBO Molecular Medicine. 13(12). e15098–e15098. 30 indexed citations
17.
Milà‐Alomà, Marta, Gemma Salvadó, Mahnaz Shekari, et al.. (2021). Comparative Analysis of Different Definitions of Amyloid-β Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer. The Journal of Prevention of Alzheimer s Disease. 8(1). 68–77. 11 indexed citations
18.
Bucci, Marco, Irina Savitcheva, Gill Farrar, et al.. (2021). A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images. European Journal of Nuclear Medicine and Molecular Imaging. 48(7). 2183–2199. 26 indexed citations
19.
Shekari, Mahnaz, et al.. (2015). Optimizing Image Reconstruction Parameters in Time of Flight PET/CT Imaging: a Phantom Study. SHILAP Revista de lepidopterología. 2(3). 146–154. 3 indexed citations
20.
Ghafarian, Pardis, et al.. (2015). The Impact of Point Spread Function Modeling on Scan Duration in PET Imaging. SHILAP Revista de lepidopterología. 2(3). 137–145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Chiao Breakdown of academic impact, for papers by Anna Dewenter Breakdown of academic impact, for papers by Elles Konijnenberg Breakdown of academic impact, for papers by Michelle Zanette Breakdown of academic impact, for papers by David N. Soleimani‐Meigooni Breakdown of academic impact, for papers by Jenna Stevenson Breakdown of academic impact, for papers by Emma M. Coomans Breakdown of academic impact, for papers by Daisuke Yanase Breakdown of academic impact, for papers by Dawn Cutler Breakdown of academic impact, for papers by Beth Kuczynski
Rankless by CCL
2026